The global market for Kidney Dialysis Equipment and Supplies is projected to reach US$24.1 billion by the year 2024, driven by the growing number of ESRD patients requiring dialysis therapy, rising awareness about kidney disease and therapy modalities, improving access to dialysis treatment, and technological advancements.
Dialysis is a clinically-guided process through which filtration of waste materials present in the blood is performed with the help of specially designed equipment. Blood filtration is generally carried out by kidneys, however due to impairment or failure of kidneys, the function has to be done with the aid of dialysis equipment. Sharp increase in the number of patients suffering from End-Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD) and subsequent rise in demand for dialysis treatment is generating sustained demand for equipment and supplies utilized in kidney dialysis. Hospitals and other care facilities are procuring large volumes of equipment & supplies to address the treatment needs of growing dialysis patient population. While such demand remains higher in the developed regions including the US, Canada, Japan and Europe, developing regions are also seen exhibiting growing demand on the back of rising awareness about the kidney disease and therapy modalities.
Demand continues to increase for equipment utilized in both the types of dialysis procedures - Hemodialysis (HD), the widely used method mainly intended for ESRD patients, and Peritoneal Dialysis (PD), designed for renal failure patients that can also function as the alternative to HD method. Consequently, sales of hemodialysis machines, blood pumps, catheters, dialyzers, dialysates and hemodialysis tubing kits, intended for HD treatment; and cycler machines, tubing kits, dialysates and catheters intended for PD treatment are growing.
Technological improvements are also aiding the market expansion. Modern equipment are being made available in compact, portable and wearable versions, with full support for home dialysis and nocturnal dialysis methods. Enhanced use of digital technologies and integration of innovative components to further improve the efficacy and quality of dialysis treatment are infusing new momentum in to the market.
The US constitutes the largest market worldwide, supported by the presence of a large number of dialysis patients, high adoption of new technologies, easy access to dialysis facilities, and favorable medical reimbursement policies. Asia-Pacific ranks as the fastest growing market with a CAGR of 9.2% over the analysis period, driven by large base of untreated ESRD patients, increasing awareness among patients about various dialysis treatment modalities, rising healthcare spending, and improving access to dialysis centers.
Major players in the market include Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International Inc., DaVita Kidney Care, Diaverum, Fresenius Medical Care AG & Co. KGaA, Fresenius Medical Care North America, JMS Co. Ltd., Kawasumi Laboratories, Medical Components Inc., Medivators Inc., Nikkiso Group, Rockwell Medical Technologies Inc., Teleflex Medical, Terumo Corporation, Toray Medical Co. Ltd., and Trividia Health among others.